Mitsubishi UFJ Asset Management
SKBI

Mitsubishi UFJ Asset Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15,000
Closed -$87K – 866
2013
Q3 		$87K Hold
15,000
– – ﹤0.01% 758
2013
Q2 		$18K Buy
+15,000
New +$21.2K ﹤0.01% 794

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Mitsubishi UFJ Asset Management's SKBI Position: Q4 2013 in Review

Mitsubishi UFJ Asset Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2013, closing a stake of 15,000 shares — an estimated $87K sold.

Mitsubishi UFJ Asset Management first reported a position in SKBI in Q2 2013 and held it in 2 quarters. The position peaked at $87K in Q3 2013. 6 funds tracked by Wall St. Rank hold SKBI as of Q4 2013.

  • Mitsubishi UFJ Asset Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2013 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 15,000 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2013, an estimated $87K.
  • Mitsubishi UFJ Asset Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q2 2013 and held it in 2 quarters.
  • Mitsubishi UFJ Asset Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $87K in Q3 2013.
  • 6 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2013.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2013, filed 10 Feb 2014.